IFIT3 could be related to immune response to SARS-CoV-2 infection based on the findings of several studies, demonstrating that IFIT3 is strongly expressed in the pulmonary inflammatory cells of patients with COVID-19 (Shaath et al., 2020; Vishnubalaji et al., 2020). This evidence concerns the gene IFIT3 and COVID-19.